How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

被引：11
作者：
Louie, TJ
机构：
[1] Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada
[2] Calgary Hlth Reg Hosp, Calgary, AB, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2005年 / 173卷 / 09期
关键词：
D O I：
10.1503/cmaj.051212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1049 / 1050
页数：2
相关论文
共 12 条
[1]   Hospital-wide restriction of clindamycin:: Effect on the incidence of Clostridium difficile-associated diarrhea and cost [J].
Climo, MW ;
Israel, DS ;
Wong, ES ;
Williams, D ;
Coudron, P ;
Markowitz, SM .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) :989-+
[2]   Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies [J].
Dial, S ;
Alrasadi, K ;
Manoukian, C ;
Huang, A ;
Menzies, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :33-38
[3]   Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea:: This is an antimicrobial resistance problem [J].
Gerding, DN .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :646-648
[4]   Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. [J].
Johnson, S ;
Samore, MH ;
Farrow, KA ;
Killgore, GE ;
Tenover, FC ;
Lyras, D ;
Rood, JI ;
DeGirolami, P ;
Baltch, AL ;
Rafferty, ME ;
Pear, SM ;
Gerding, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) :1645-1651
[5]  
MCDONALD LC, 2004, 42 ANN M INF DIS SOC
[6]   Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec [J].
Pépin, J ;
Valiquette, L ;
Cossette, B .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (09) :1037-1042
[7]   Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003:: a changing pattern of disease severity [J].
Pépin, J ;
Valiquette, L ;
Alary, ME ;
Villemure, P ;
Pelletier, A ;
Forget, K ;
Pépin, K ;
Chouinard, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (05) :466-472
[8]   ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE PRODUCED BY A CLOSTRIDIUM-DIFFICILE STRAIN [J].
POPOFF, MR ;
RUBIN, EJ ;
GILL, DM ;
BOQUET, P .
INFECTION AND IMMUNITY, 1988, 56 (09) :2299-2306
[9]   Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates [J].
Spigaglia, P ;
Mastrantonio, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3470-3475
[10]  
VANSTEENBERGEN J, 2005, EUROSURVEILLANCE, P10
12